Position in RXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$807,400
+$807,400 QoQ
Shares Held
220,000
Ownership
0.041%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#80
of 338 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in RXRX
reported options exposure · as of Jun 30, 2026CallValue
$601,513
CallShares
163,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PEAK6 LLC holds $19,544,893 across 28 Biotechnology names. RXRX ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
67,942 | $4,800,102 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
29,460 | $2,335,883 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,231 | $1,875,717 | |
| 4 | EDIT |
Editas Medicine, Inc.
|
415,441 | $1,346,028 | |
| 5 | BNTX |
BioNTech SE
|
13,584 | $1,263,991 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
22,316 | $1,217,114 | |
| 7 | ASND |
Ascendis Pharma A/S
|
3,764 | $1,003,934 | |
| 8 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
220,000 | $807,400 |
All Filings in RXRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $601,513 | 163,900 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $807,400 | 220,000 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $460,500 | 150,000 | Call | Defined | 2026-05-14 | |
| 2025-12-31 | $6,674,880 | 1,632,000 | Call | Defined | 2026-03-12 | |
| 2025-09-30 | $6,031,680 | 1,236,000 | Call | Defined | 2026-03-31 | |
| 2025-06-30 | $7,330,928 | 1,448,800 | Call | Defined | 2026-03-26 | |
| 2025-03-31 | $376,119 | 71,100 | Call | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||